3rd Circ. Rejects Lovenox Antitrust Suit Against Sanofi
The Third Circuit on Wednesday rejected pharmaceutical manufacturer Eisai's bid to reinstate an antitrust lawsuit against Sanofi over discount contracts with hospitals that purchased large amounts of anti-coagulant drug Lovenox, saying...To view the full article, register now.
Already a subscriber? Click here to view full article